Genetic News and Research

RSS

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS).

26 Aug 2013

Researchers discover additional cystic fibrosis-causing mutations

Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.

26 Aug 2013

Study identifies 22 locations in the human genome that cause schizophrenia

A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.

26 Aug 2013

Higher intake of fruits and vegetables may reduce risk of bladder cancer in women: Study

University of Hawaii Cancer Center Researcher Song-Yi Park, PhD, along with her colleagues, recently discovered that a greater consumption of fruits and vegetables may lower the risk of invasive bladder cancer in women.

26 Aug 2013

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

26 Aug 2013

Glutathione peroxidase activity protects against symptoms of Huntington's disease

Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.

26 Aug 2013

DeNovoGear software uses statistical probabilities to help identify genetic mutations

Concealed within the vastness of the human genome, (comprised of some 3 billion base pairs), mutations are commonplace. While the majority of these appear to have neutral effect on human health, many others are associated with diseases and disease susceptibility.

26 Aug 2013

Scientists Shed New Light On Malignant Pancreatic Cancer

...

23 Aug 2013

Athera Transfers Annexin A5 Project To Medirista

...

23 Aug 2013

Shire Renews Rare Genetic Disease Collab With Santaris

...

23 Aug 2013

Athera Transfers Annexin A5 Project To Medirista

...

23 Aug 2013

Shire Renews Rare Genetic Disease Collab With Santaris

...

23 Aug 2013

Scientists discover that chromosomal rearrangements can be advantageous

In a pioneer study published in the latest issue of the scientific journal Nature Communications, a research team at the Instituto Gulbenkian de Ci-ncia (IGC; Portugal), led by Miguel Godinho Ferreira in collaboration with Isabel Gordo, show for the first time that chromosomes rearrangements (such as inversions or translocations) can provide advantages to the cells that harbor them depending on the environment they are exposed.

23 Aug 2013

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Mentors International and Co-Diagnostics HBDC signed an agreement to lower real-time PCR test prices in the developing world, starting with tuberculosis. Under the agreement, Co-Diagnostics HBDC will provide low-cost testing reagents and Mentors International will leverage its international connections to set up low-cost testing facilities.

23 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Age, sex and race may predict risk factor reduction in patients with coronary heart disease

Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.

23 Aug 2013

Understanding genetic factors that affect Crohn's disease risk

A statistical model accounting for dozens of different genes in combination—and the interactions between them—is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease, reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.

23 Aug 2013

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

Variants in a particular gene are linked with an increased risk for kidney complications in patients with lupus, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings could lead to better treatments to protect the kidney health of patients with the disease.

23 Aug 2013

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

A person's skin pigment, which determines hair color and skin tone, is influenced by the melanocortin-1 (MC1R) gene receptor. For the population's one to two percent of redheads, a mutation in MC1R accounts for their red hair color and typical light skin.

23 Aug 2013

Brain Study Suggests New Way To Treat Anxiety

...

22 Aug 2013

Genetic News and Research

Scientists receive NIH grant to study commercially-available drug for treatment of PMS

Researchers discover additional cystic fibrosis-causing mutations

Study identifies 22 locations in the human genome that cause schizophrenia

Higher intake of fruits and vegetables may reduce risk of bladder cancer in women: Study

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

Glutathione peroxidase activity protects against symptoms of Huntington's disease

DeNovoGear software uses statistical probabilities to help identify genetic mutations

Scientists Shed New Light On Malignant Pancreatic Cancer

Athera Transfers Annexin A5 Project To Medirista

Shire Renews Rare Genetic Disease Collab With Santaris

Athera Transfers Annexin A5 Project To Medirista

Shire Renews Rare Genetic Disease Collab With Santaris

Scientists discover that chromosomal rearrangements can be advantageous

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Age, sex and race may predict risk factor reduction in patients with coronary heart disease

Understanding genetic factors that affect Crohn's disease risk

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

Brain Study Suggests New Way To Treat Anxiety

Sequencing & Genomics: Elevating Science and Healthcare eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News